The trademark IPMOZYL was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on May 12, 2008, and received one opposition filed on August 12, 2008 by MENARINI FRANCE S.A. on Likelihood of confusion. the opponent was represented by CABINET GEFIB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 12, 2008
The application was filed in Swedish, and Swedish was also language of all opposition proceedings (English was selected as the second language).
The renewal of the trademark was recorded by the office on October 21, 2018.
of the trademark registration was recorded on October 21, 2018. Change of name and address of the trademark registration was recorded on October 24, 2009. Appointment and Replacement of representative of the trademark registration was recorded on September 18, 2018.